Topic - John Castellani

Subscribe to this topic via RSS or ATOM
Related Stories
  • BITTER PILL: John Castellani, president and CEO of PhRMA, cautions against cutting from 12 years to seven the length of a patent on a company's new drug. (J.M. Eddins Jr./The Washington Times)

    PhRMA president calls Obama policy 'wrongheaded'

    The chief spokesman for pharmaceutical manufacturers says President Obama has stuck two thorns in the industry's side at a time marked by uncertainty as lawmakers contemplate cutting health care programs and battles over the new health care law wind their way through the courts.

More Stories →

Happening Now